SavedAdd your journal

Journals / Ankara Medical Journal / 2018 / Cilt: 18 - Sayı: 3

Depression in Rheumatoid Arthritis: Association with Quality of Life, Function and Disease Activity

Romatoid Artritte Depresyon: Yaşam Kalitesi, Fonksiyon ve Hastalık Aktivitesi ile İlişkisi

Hatice BODUR
Ayşegül KILIÇARSLAN
Yeşim Garip ÇİMEN
Aslı ÇALIŞKAN UÇKUN
Fatma GÜL YURDAKUL
Pages
337–344
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RA patientsscored significantly higher in BDS when compared with the controls (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of our study is to evaluate the depression rate in patients with rheumatoid arthritis(RA) and its association with pain, disease activity, functional status, and various health related qualityof life (HRQoL) domains in terms of functional status, vitality, social and emotional functioning.Materials and Methods: A total of 90 RA patients and 50 sex and age matched controls were includedin the study.
📊
Key Findings & Data:Demographic characteristics, erythrocyte sedimentation rates, C‐reactive protein, tenderand swollen joint count, patient and physician global assessment of disease activity were recorded.Disease Activity Score‐28 (DAS28) was used for measuring disease activity.
💡
Conclusion & Impact:RA patientsscored significantly higher in BDS when compared with the controls (p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The aim of our study is to evaluate the depression rate in patients with rheumatoid arthritis(RA) and its association with pain, disease activity, functional status, and various health related qualityof life (HRQoL) domains in terms of functional status, vitality, social and emotional functioning.Materials and Methods: A total of 90 RA patients and 50 sex and age matched controls were includedin the study. Demographic characteristics, erythrocyte sedimentation rates, C‐reactive protein, tenderand swollen joint count, patient and physician global assessment of disease activity were recorded.Disease Activity Score‐28 (DAS28) was used for measuring disease activity. The severity of pain wasdetermined by using 10 cm Visual Analog Scale‐Pain (VAS‐pain). HRQoL was evaluated by using ShortForm 36 (SF 36).HAQ (Health Assessment Questionnaire) was used for evaluation of the functional status. Depressionwas evaluated by using Beck Depression Scale (BDS).Results: Mean age was 54.51±12.54 in RA (75 women, 15 men) group and 51.94±9.69 in the control group(41 women, 9 men). Mean VAS‐pain was 55.85±26.24; HAQ was 1.27±0.81 and DAS28 was 5.04 ±2.44 inRA patients. The mean BDS was 19.67±13.11 in RA group and 6.64±6.73 in the control group. RA patientsscored significantly higher in BDS when compared with the controls (p

Özet

Amaç: Çalışmamızın amacı romatoid artritli (RA) hastalarda ağrı, hastalık aktivitesi, fonksiyonel durum ve vitalite, fonksiyonellik, sosyal ve duygusal işlevsellik gibi sağlıkla ilişkili yaşam kalitesi (HRQoL) alanları arasındaki ilişkiyi değerlendirmektir. Materyal ve Metot: Çalışmaya toplam 90 RA hastası ve 50 cinsiyet ve yaş uyumlu kontrol dahil edildi. Demografik özellikler, eritrosit sedimantasyon oranları, C‐reaktif protein, hassas ve şiş eklem sayısı, hasta ve hekimin global değerlendirmesi kaydedildi. Hastalık aktivitesini ölçmek için Hastalık Aktivite Skoru‐28 (DAS28) kullanıldı. Ağrının şiddeti, 10 cm Görsel Analog Skala‐Ağrı (VAS‐ağrı) kullanılarak belirlendi. HRQoL, Kısa Form 36 (SF 36) kullanılarak değerlendirildi. Fonksiyonel durumun değerlendirilmesi için HAQ (Sağlık Değerlendirme Anketi) kullanıldı. Depresyon, Beck Depresyon Ölçeği (BDS) kullanılarak değerlendirildi. Bulgular: Yaş ortalaması RA'da (54 kadın, 15 erkek) 54,51 ± 12,54; kontrol grubunda (41 kadın, 9 erkek) 51,94 ± 9,69 idi. RA'lı hastalarda ortalama VAS 55,85 ± 26,24 idi; HAQ 1,27 ± 0,81, DAS28 ise 5,04 ± 2,44 idi. RA grubunda ortalama BDS 19,67 ± 13,11 ve kontrol grubunda 6,64 ± 6,73 idi. RA hastalar kontrol grubu ile karşılaştırıldığında, BDS'de anlamlı olarak daha yüksek puan aldı (p

🔖

Cite This Article

BODUR, H., KILIÇARSLAN, A., ÇİMEN, Y. G., UÇKUN, A. Ç., YURDAKUL, F. G. (2022). Depression in Rheumatoid Arthritis: Association with Quality of Life, Function and Disease Activity. Ankara Medical Journal, Cilt: 18 - Sayı: 3, 337–344. https://ajindex.com/articles/441962

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12‐month DSM‐IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:617‐27
  2. Walker JR, Lesley AG, Dutz JP, Bernstein CN. Psychiatric disorders in patients with immunemediated inflammatory diseases: prevalence, association with disease activity, and overall patient well‐being. J Rheumatol Suppl 2011;88:31‐5
  3. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010;376:1094‐108
  4. Strand V, Khanna D. The impact of rheumatoid arthritis and treatment on patients' lives. Clin Exp Rheumatol 2010;28:32‐40
  5. Aletaha D, Neogi T, Silman AJ et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569‐81
  6. Prevoo MLL, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty‐eight‐joint counts. Arthritis Rheum 1995;38:44‐8
  7. Price DD, McGrath P, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45‐56
  8. Ware JE Jr, Sherbourne CD. The MOS 36‐item short‐form health survey (SF‐36). I. Conceptual framework and item selection. Med Care 1992;30:473‐83
  9. Küçükdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A. Issues in Cross‐ Cultural Validity: Example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis and Rheumatism 2004;51:14‐9
  10. Hisli N. Beck Depresyon Envanterinin Üniversite Öğrencileri için Geçerliliği ve Güvenirliği. Psikoloji Dergisi 1989;7:3‐13
  11. Pignone MP, Gaynes BN, Rushton JL et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;36:765‐76
  12. Iverson GL. Screening for depression in systemic lupus erythematosus with the British Columbia Major Depression Inventory. Psychol Rep 2002;90:1091‐6
  13. Thombs BD, Hudson M, Taillefer SS, Baron M. Canadian Scleroderma Research Group Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 2008;59:504‐9
  14. Nicassio PM. The problem of detecting and managing depression in the rheumatology clinic. Arthritis Rheum 2008;59:155‐8
  15. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid a